Middle East respiratory syndrome coronavirus vaccine (GeneOne Life Sciences/Inovio Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMiddle East respiratory syndrome coronavirus vaccine (GeneOne Life Sciences/Inovio Pharmaceuticals)
Drug Alias NameMiddle East respiratory syndrome coronavirus vaccineMERS DNA vaccineINO-4301INO-4700GLS-5300
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMiddle East Respiratory Syndrome CoronavirusCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJordanLebanon +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInovio Pharmaceuticals IncWalter Reed Army InstituteCoalition for Epidemic Preparedness Innovations +[4] 
Inactive CompaniesN/A
Active IndicationsMiddle East Respiratory Syndrome CoronavirusCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A